A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease Maria Jimenez Ramos; Timothy J. Kendall; Ignat Drozdov; Jonathan A. Fallowfield;

Alpha-1 antitrypsin Pi*MZ variant increases the risk of liver disease progression in MASLD and MASH Bradley Jermy; Jack Brownrigg; Pavel Strnad; Rohit Loomba;

Is FIB-4 the right tool for screening for liver fibrosis? Leen JM. Heyens; Demi P.A.van Malde; Gediz Dogay Us; Francesco Innocenti; Mathieu Struyve; Christophe Van Steenkiste; Sven Francque; Geert Robaeys; Ger H. Koek;